Literature DB >> 12096719

Binding of imatinib by alpha(1)-acid glycoprotein.

Carlo Gambacorti-Passerini, Philipp le Coutre, Massimo Zucchetti, Maurizio D'Incalci.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12096719     DOI： 10.1182/blood-2002-02-0518

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein.

Authors:  N Widmer; L A Decosterd; C Csajka; S Leyvraz; M A Duchosal; A Rosselet; B Rochat; C B Eap; H Henry; J Biollaz; T Buclin
Journal:  Br J Clin Pharmacol       Date:  2006-07       Impact factor: 4.335

2.  Adaphostin-induced oxidative stress overcomes BCR/ABL mutation-dependent and -independent imatinib resistance.

Authors:  Joya Chandra; Jeannette Tracy; David Loegering; Karen Flatten; Srdan Verstovsek; Miloslav Beran; Mercedes Gorre; Zeev Estrov; Nicholas Donato; Moshe Talpaz; Charles Sawyers; Kapil Bhalla; Judith Karp; Edward Sausville; Scott H Kaufmann
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

Review 3.  Imatinib mesylate in combination with other chemotherapeutic agents for chronic myelogenous leukemia.

Authors:  Tetsuzo Tauchi; Kazuma Ohyashiki
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

4.  Clinical Relevance of ABCB1, ABCG2, and ABCC2 Gene Polymorphisms in Chronic Myeloid Leukemia Patients Treated With Nilotinib.

Authors:  Federica Loscocco; Giuseppe Visani; Annamaria Ruzzo; Irene Bagaloni; Fabio Fuligni; Sara Galimberti; Antonello Di Paolo; Fabio Stagno; Patrizia Pregno; Mario Annunziata; Antonella Gozzini; Sara Barulli; Elisa Gabucci; Mauro Magnani; Alessandro Isidori
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

5.  Depletion of γ-catenin by Histone Deacetylase Inhibition Confers Elimination of CML Stem Cells in Combination with Imatinib.

Authors:  Yanli Jin; Yiwu Yao; Li Chen; Xiaohui Zhu; Bei Jin; Yingying Shen; Juan Li; Xin Du; Yuhong Lu; Sheng Jiang; Jingxuan Pan
Journal:  Theranostics       Date:  2016-08-12       Impact factor: 11.556

6.  Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure.

Authors:  Sander Bins; Karel Eechoute; Jacqueline S L Kloth; Femke M de Man; Astrid W Oosten; Peter de Bruijn; Stefan Sleijfer; Ron H J Mathijssen
Journal:  Clin Pharmacokinet       Date:  2017-03       Impact factor: 6.447
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.